Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Caitlin E. Cox

February 02, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Daily News

NSAIDs Tied to HF Hospitalization in Patients With Diabetes

L.A. McKeown

April 10, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Todd Neale

December 09, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Shelley Wood

August 04, 2021

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

L.A. McKeown

May 31, 2017

Advertisement

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

NSAIDs Tied to HF Hospitalization in Patients With Diabetes

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content